The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Penn Medicine partners with Mark Cuban’s Cost Plus Drugs to increase medication supply, reduce costs
The collaboration will provide Penn Medicine with a selection of 100 of the most commonly dispensed medications while ...
The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked ...
The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...
If all drug manufacturers would sell to Cost Plus Drugs at a competitive price, then all drugs would be available at cost plus 15%, and the amount of money spent on drugs would decline ...
Hays and her husband who have a Medicare Part D drug plan. As a result, she expects to shell out a lot less at the pharmacy ...
The Mark Cuban Cost Plus Drug Company will begin manufacturing its own medications in Texas this week, cofounder and CEO Dr. Alex Oshmyansky announced Monday during a White House roundtable on ...
The billionaire, who launched Mark Cuban Cost Plus Drugs in 2022 to upend the byzantine $500 billion U.S. drug market, is convinced that the Lewandowski suit and others will end the dominance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback